Affiliation:
1. GITAM School of Pharmacy, GITAM (Deemed to be) University, Visakhapatnam-530045, India.
Abstract
Ziprasidone hydrochloride monohydrate is an atypical antipsychotic drug which acts by antagonizing the dopamine type 2 (D2) and serotonin type 2 (5HT2A) receptors. It is used for the treatment of schizophrenia as well as manic and bipolar disorders. Two new spectrophotometric methods have been developed for the determination of Ziprasidone capsules in acetate buffer (pH 4.0) (λmax 315.00 nm) (Method I) and phosphate buffer (pH 5.0) (λmax 315.40 nm) (Method II) respectively and the methods were validated. Beer-Lambert’s law was obeyed over the concentration range 0.5-30 µg/mL and 1-120 µg/mL in acetate buffer and phosphate buffer respectively. The proposed methods were applied to the Ziprasidone marketed formulations and the methods were found to be simple, precise and accurate.
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference19 articles.
1. Mattei C, Rapagnani MP and Stahl SM. Ziprasidone Hydrochloride: what role in the management of schizophrenia? J Cent Nerv Syst Dis. 2011; 3: 1-16.
2. Kutcher S, Brooks SJ, Gardner DM, Honer B, Kopala L, Labelle A, Lalonde P, Malla A, Milliken H, Soni J and Williams R. Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders. Neuropsychiatr Dis Treat. 2005; 1(2): 89-108.
3. Walash MI, Belal F, El-Enany, Manal Eid and Rania N El-Shaheny. Stability-indicating spectrofluorimetric method for the assay of Ziprasidone in capsules. Journal of Fluorescence, 2011; 21: 1659-1667.
4. Anand Kumar Y, Anitha M, Hemanth A and Srinivas S. Development of rapid UV spectrophotometric method for the estimation of Ziprasidone Hydrochloride in bulk and formulations. Digest Journal of Nanomaterials and Biostructures. 2010; 5(1): 275-279.
5. Mahale MV, Todkari VB, Kangane MR, Mohite SK, Magdum CS and Hembade MJ. U.V. spectrophotometric method development for quantitative estimation of Ziprasidone hydrochloride. International Journal of Pharmaceutical Archive. 2013; 2(5): 92-94.